Skip to content

DRIVing Simulator and People With NeuroCognitive Disorders

Driving Simulator and People With Neurocognitive Disorders

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06320639
Acronym
DRIVS-NCD
Enrollment
150
Registered
2024-03-20
Start date
2023-10-03
Completion date
2026-10-10
Last updated
2024-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurocognitive Disorders

Keywords

Alzheimer's Disease, Vascular encephalopathy, Parkinson's Disease

Brief summary

The ageing of the population is leading to an increasing number of older drivers on the roads. At the same time, the proportion of older people with pathological ageing and neurocognitive disorders (NCD) is increasing. In terms of road safety, this raises the question of whether these drivers should continue to drive or not. People with NCDs may not be aware of the presence, extent and progression of their cognitive impairment and the impact it can have on daily life, including driving. Despite their loss of autonomy and medical advice, 22% of people with major NCD continue to drive. In addition, the presence of minor NCD also puts people at a higher risk of road accidents. However, several studies demonstrated that an NCD does not lead to a systematic and immediate impairment of driving ability and abruptly stopping driving leads to health problems, such as the risk of depression and greatly reduces quality of life. It is therefore relevant to focus research on driving with people with NCD in order to have a reliable indicator of the person's abilities and the impact of their cognitive impairment on driving activity. The proposed study seeks to meet this need by studying the performance of people with NCD on a driving station (mini-simulator) while assessing their ability to evaluate their performance. To achieve this goal, people with NCDs will perform tasks on a driving simulator. In addition, after each task on the driving simulator, they will answer questions about how they evaluate their own driving. Two assessors will observe the participants' driving and will estimate their driving performance. By comparing the driver's self-assessment with the assessors' assessment, an awareness score of driving ability will be calculated to determine whether the driver correctly assessed his or her performance. Another project already underway aims to collect similar data from people without a diagnosis of NCDs (control group). The principal objective of the present study is to compare the driving performance in a simulator and the awareness of driving ability of people with NCDs with those of a control group. Secondary objectives are : 1. to measure driving performance in a simulator and awareness of driving abilities (i.e. self-assessment skills) of people with NCDs. 2. to analyse driving performance and awareness of driving abilities according to the diagnosis and severity of the disorder (i.e. minor or major neurocognitive disorders). 3. to establish a methodology to identify a driver at risk of dangerous driving. It is mainly an exploratory study however some hypotheses can be made : * The driving performance and awareness of driving skills of people with NCDs are poorer compared to those of older, control individuals. * Individuals' driving performance and awareness of driving ability are lower in the presence of major NCDs compared to minor NCDs.

Interventions

None listed

Sponsors

Hospices Civils de Lyon
CollaboratorOTHER
University Gustave Eiffel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Neurocognitive Disorders according to the Diagnostic and Statistical Manual of Mental Disorders-V (DSM-V) * Normal or corrected vision * B licence holder with 3+ years driving experience * Active drivers or drivers who stopped driving less than 2 months ago (time between the medical consultation and the day in the day care hospital) * For participants able to give consent: * Written informed consent to participate in the study * Informed consent of the participant in the presence of his/her curator. * For participants who are not able to receive information and to give consent: * Written informed consent of the legal representative (tutor) for participants under tutelage. * Signature of a relative (family member and/or trusted person) of the participant * The participant has to be affiliated to a social security scheme.

Exclusion criteria

* History of epilepsy * People with vestibular disorders, motion sickness or migraines * Psychiatric history (e.g. schizophrenia) * Non-stabilized use of antidepressants and/or anxiolytics (started or modified within the last 3 months) * History of alcoholism * Use of anti-epileptics * Osteo-articular pathologies compromising walking

Design outcomes

Primary

MeasureTime frameDescription
Awareness score of driving abilityUp to 2 hours, from the inclusion until the end of the experiment (2 hours later)After each task on the driving simulator, participants answer questions about what they think of their driving performance. Two experimenters write their observations about the participant's performance. Answers are coded in a way that a greater driving performance lead to a greater score. The Awareness score is computed by subtracting the score given by the participant to the average of the scores given by the experimenters. The further away from zero the score is, the less aware the participants will be of their abilities. Zero will indicate a perfect assessment of one's abilities.
Driving performance variables measured by the driving simulatorUp to 2 hours, from the inclusion until the end of the experiment (2 hours later)For each driving task, the driving variables of interest from the driving simulator will be collected: total braking response time, average speed and lateral lane position for the keeping lane task; distance between vehicles for the car-tracking task; reaction time to unexpected events for the rural and urban driving tasks.

Countries

France

Contacts

Primary ContactMaud Ranchet, PhD
maud.ranchet@univ-eiffel.fr0472142599
Backup ContactMarion Giroux, PhD
marion.giroux@chu-lyon.fr0472432372

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026